Drug giant Pfizer to split into three units, including a new hospital business

FAN Editor

U.S. drugmaker Pfizer said on Wednesday it would reorganize its business into three units and one of them would include a new hospital business segment.

The three units are biosimilars and hospital business, branded and generic medicines and consumer health care, the company said.

The changes would be effective beginning fiscal 2019.

A day earlier, Pfizer announced it would postpone drug price hikes after an “extensive” conversation between the company’s CEO and President Donald Trump.

“Pfizer shares the President’s concern for patients and commitment to providing affordable access to the medicines they need,” Pfizer CEO Ian Read said in a statement.

CNBC contributed to this report.

Free America Network Articles

Leave a Reply

Next Post

Homebuyers fuel jump in mortgage applications, as more listings finally emerge

A slight increase in the number of homes for sale may be helping to juice the mortgage market. After falling for two straight weeks, mortgage application volume rose 2.5 percent last week, seasonally adjusted, compared to the previous week. The increase was driven entirely by purchase applications. Still, total volume […]